Astria Therapeutics Inc. has announced new compensation terms under its 2022 Inducement Stock Incentive Plan. On August 1, 2025, the company granted stock options to purchase 180,000 shares of its common stock as part of an inducement for two new employees. These options, set at an exercise price of $6.56 per share, equal to the stock's closing price on the grant date, will vest over four years. The vesting schedule includes 25% of the shares vesting on the first anniversary of the employees' start date, with the remaining shares vesting monthly over the subsequent 36 months, contingent on their ongoing employment with Astria.